WT1 Peptide Cancer Vaccine for Patients with Hematopoietic Malignancies and Solid Cancers
Wild-type Wilms' tumor gene WT1 is expressed at a high level in hematopoietic malignancies including acute leukemia, chronic myelogenous leukemia, and myelodysplastic syndromes, as well as in various kinds of solid cancers. Human cytotoxic T lymphocytes (CTLs), which could specifically lyse WT1...
Saved in:
Main Authors: | Yoshihiro Oka, Akihiro Tsuboi, Olga A. Elisseeva, Hiroko Nakajima, Fumihiro Fujiki, Manabu Kawakami, Toshiaki Shirakata, Sumiyuki Nishida, Naoki Hosen, Yusuke Oji, Ichiro Kawase, Haruo Sugiyama |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2007-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2007.119 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spontaneous high clonal expansion of Wilms’ tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms’ tumor gene 1-expressing solid tumor
by: Soyoko Morimoto, et al.
Published: (2024-11-01) -
Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1–Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study
by: Prashasti Agrawal, MD, et al.
Published: (2025-01-01) -
Liquid Phase Separation Mechanism of Cu-40 wt.% Pb Hypermonotectic Alloys
by: Xiaosi Sun, et al.
Published: (2018-01-01) -
An intelligent system for lung CT image denoising using a hybrid WT-NLM filter
by: S.L. Soniya, et al.
Published: (2025-04-01) -
SSNMR confirms silicate ion substitution in the apatitic structure of 0.8wt% Si hydroxyapatite
by: Marc-Krystelle Mafina, et al.
Published: (2023-11-01)